相似文献
1
Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates.
J Clin Microbiol. 2007 Aug;45(8):2740-2. doi: 10.1128/JCM.01093-07. Epub 2007 Jun 13.
2
Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Int J Antimicrob Agents. 2010 Jan;35(1):76-9. doi: 10.1016/j.ijantimicag.2009.08.003. Epub 2009 Sep 24.
3
Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Int J Antimicrob Agents. 2011 Mar;37(3):253-5. doi: 10.1016/j.ijantimicag.2010.11.022. Epub 2011 Jan 13.
4
Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
Int J Antimicrob Agents. 2010 Apr;35(4):387-91. doi: 10.1016/j.ijantimicag.2009.12.005.
5
Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
Microb Drug Resist. 2011 Sep;17(3):363-7. doi: 10.1089/mdr.2011.0034. Epub 2011 May 12.
6
Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Int J Antimicrob Agents. 2012 Dec;40(6):516-20. doi: 10.1016/j.ijantimicag.2012.07.019. Epub 2012 Oct 13.
7
Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
J Microbiol. 2005 Oct;43(5):391-7.
8
Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections.
Scand J Infect Dis. 2011 Feb;43(2):83-8. doi: 10.3109/00365548.2010.526632. Epub 2010 Oct 14.
9
Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
Chemotherapy. 2012;58(1):52-9. doi: 10.1159/000336129. Epub 2012 Feb 15.
10
[Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Wei Sheng Yan Jiu. 2004 Sep;33(5):591-4.
引用本文的文献
1
The First Report of -1-Carrying , Isolated from a Clinical Sample in the North-East of Romania.
Microorganisms. 2024 Nov 29;12(12):2461. doi: 10.3390/microorganisms12122461.
2
Evolution of Resistance against Ciprofloxacin, Tobramycin, and Trimethoprim/Sulfamethoxazole in the Environmental Opportunistic Pathogen .
Antibiotics (Basel). 2024 Apr 5;13(4):330. doi: 10.3390/antibiotics13040330.
3
Evolution of antimicrobial resistance in biofilm treated with high doses of ciprofloxacin.
Front Microbiol. 2023 Sep 5;14:1246895. doi: 10.3389/fmicb.2023.1246895. eCollection 2023.
4
Prevalence and mechanisms of ciprofloxacin resistance in Escherichia coli isolated from hospitalized patients, healthy carriers, and wastewaters in Iran.
BMC Microbiol. 2023 Jul 17;23(1):191. doi: 10.1186/s12866-023-02940-8.
5
Prevalence and Characterization of Extended-Spectrum β-Lactamase-Producing Isolated from Dogs and Cats in South Korea.
Antibiotics (Basel). 2023 Apr 13;12(4):745. doi: 10.3390/antibiotics12040745.
6
Genotypic and Phenotypic Characterization of Antimicrobial Resistance Profiles in Non-typhoidal Strains Isolated From Cambodian Informal Markets.
Front Microbiol. 2021 Sep 16;12:711472. doi: 10.3389/fmicb.2021.711472. eCollection 2021.
7
Genome profiling of fluoroquinolone-resistant uropathogenic Escherichia coli isolates from Brazil.
Braz J Microbiol. 2021 Sep;52(3):1067-1075. doi: 10.1007/s42770-021-00513-3. Epub 2021 Jun 8.
8
Phylogenomic Investigation of Increasing Fluoroquinolone Resistance among Belgian Cases of Shigellosis between 2013 and 2018 Indicates Both Travel-Related Imports and Domestic Circulation.
Microorganisms. 2021 Apr 6;9(4):767. doi: 10.3390/microorganisms9040767.
9
Detection of gyrA and parC Mutations and Prevalence of Plasmid-Mediated Quinolone Resistance Genes in .
Infect Drug Resist. 2021 Feb 12;14:555-563. doi: 10.2147/IDR.S275852. eCollection 2021.
10
Nybomycin inhibits both types of DNA gyrase - fluoroquinolone-sensitive and fluoroquinolone-resistant.
Antimicrob Agents Chemother. 2023 May 1;95(5). doi: 10.1128/AAC.00777-20. Epub 2021 Feb 16.
本文引用的文献
1
In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase.
Antimicrob Agents Chemother. 2006 Apr;50(4):1525-7. doi: 10.1128/AAC.50.4.1525-1527.2006.
2
High presence of extended-spectrum beta-lactamases and resistance to quinolones in clinical isolates of Escherichia coli.
Microbiol Res. 2007;162(4):347-54. doi: 10.1016/j.micres.2006.02.003. Epub 2006 Mar 27.
3
Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments.
Int J Antimicrob Agents. 2005 May;25(5):358-73. doi: 10.1016/j.ijantimicag.2005.02.006.
4
High incidence of extended-spectrum beta-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method.
Diagn Microbiol Infect Dis. 2004 Oct;50(2):131-4. doi: 10.1016/j.diagmicrobio.2004.06.003.
5
[Quinolone use and resistance].
Enferm Infecc Microbiol Clin. 2004 Apr;22(4):201-3. doi: 10.1016/s0213-005x(04)73066-9.
6
Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.
Antimicrob Agents Chemother. 2003 Oct;47(10):3222-32. doi: 10.1128/AAC.47.10.3222-3232.2003.
7
[Quinolones].
Enferm Infecc Microbiol Clin. 2003 May;21(5):261-7; quiz 268, 272. doi: 10.1016/s0213-005x(03)72932-2.
8
[Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
Enferm Infecc Microbiol Clin. 2003 Feb;21(2):77-82.
9
Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections.
Int J Antimicrob Agents. 2001 Sep;18(3):211-5. doi: 10.1016/s0924-8579(01)00389-2.
10
Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Clin Infect Dis. 2001 Oct 15;33(8):1288-94. doi: 10.1086/322667. Epub 2001 Sep 14.
Zotero 插件